| |
| |
|
| Insider
Information: |
Mcwherter Charles |
| Relationship: |
|
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2015-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2024-03-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(46,938) |
0 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2024-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
31,938 |
46,938 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2024-01-19 |
4 |
AS |
$23.66 |
$435,645 |
D/D |
(18,403) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2024-01-19 |
4 |
OE |
$1.06 |
$130,522 |
D/D |
18,403 |
18,125 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-12-18 |
4 |
AS |
$21.48 |
$243,441 |
D/D |
(11,332) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-12-18 |
4 |
OE |
$5.00 |
$56,660 |
D/D |
11,332 |
21,504 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-11-17 |
4 |
OE |
$5.00 |
$56,710 |
D/D |
11,342 |
26,342 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-11-17 |
4 |
AS |
$18.28 |
$207,293 |
D/D |
(11,342) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-10-18 |
4 |
AS |
$14.07 |
$305,941 |
D/D |
(21,743) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-10-18 |
4 |
OE |
$5.00 |
$108,715 |
D/D |
21,743 |
36,743 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-09-18 |
4 |
AS |
$16.22 |
$352,733 |
D/D |
(21,746) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-09-18 |
4 |
OE |
$5.00 |
$108,730 |
D/D |
21,746 |
36,746 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-08-18 |
4 |
AS |
$11.47 |
$249,359 |
D/D |
(21,746) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-08-18 |
4 |
OE |
$5.00 |
$108,730 |
D/D |
21,746 |
36,746 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-07-18 |
4 |
AS |
$11.43 |
$248,519 |
D/D |
(21,749) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-07-18 |
4 |
OE |
$5.00 |
$108,745 |
D/D |
21,749 |
36,749 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-06-20 |
4 |
AS |
$8.16 |
$177,383 |
D/D |
(21,749) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-06-20 |
4 |
OE |
$5.00 |
$108,745 |
D/D |
21,749 |
36,749 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-05-18 |
4 |
OE |
$5.00 |
$108,745 |
D/D |
21,749 |
36,749 |
0 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
President of R&D |
• – – |
2023-05-18 |
4 |
AS |
$9.08 |
$197,387 |
D/D |
(21,749) |
15,000 |
0 |
% |
|
| CBAY |
Cymabay Therapeutics, Inc... |
SVP & Chief Scientific Officer |
• – – |
2017-11-02 |
4 |
B |
$8.67 |
$43,341 |
D/D |
5,000 |
15,000 |
2.74 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
SVP & Chief Scientific Officer |
• – – |
2017-07-20 |
4 |
B |
$7.42 |
$37,137 |
D/D |
5,000 |
10,000 |
2.74 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Sr. Vice President |
• – – |
2016-04-15 |
4 |
B |
$1.68 |
$5,040 |
D/D |
3,000 |
5,000 |
2.74 |
- |
|
| CBAY |
Cymabay Therapeutics, Inc... |
Sr. Vice President |
• – – |
2015-05-15 |
4 |
B |
$3.14 |
$6,318 |
D/D |
2,000 |
2,000 |
2.74 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
